Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
76°
Partly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mainz Biomed N.V. - Ordinary Shares
(NQ:
MYNZ
)
0.3590
+0.0118 (+3.40%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mainz Biomed N.V. - Ordinary Shares
< Previous
1
2
3
4
5
6
7
8
9
Next >
Mainz Biomed Announces Closing of $5.0 million Registered Direct Offering
November 15, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 14, 2023
Via
Benzinga
Crude Oil Gains Over 1%; US Budget Deficit Narrows For October
November 13, 2023
U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 50 points on Monday. The Dow traded up 0.16% to 34,337.33 while the NASDAQ fell 0.11% to 13,783.41. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
November 13, 2023
Edible Garden AG Incorporated (NASDAQ: EDBL) shares fell on Monday following third-quarter results.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 13, 2023
Via
Benzinga
Why Mainz Biomed (MYNZ) Stock Is Getting Hammered
November 13, 2023
Mainz Biomed NV (NASDAQ: MYNZ) shares are trading lower by 46% to $1.21 during Monday's session has entered a securities purchase agreement with institutional investors to raise $5 million through a
Via
Benzinga
Dow Surges 100 Points; Tenax Therapeutics Shares Spike Higher
November 13, 2023
U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining around 100 points on Monday. The Dow traded up 0.33% to 34,397 while the NASDAQ fell 0.06% to 13,790. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
US Stocks Fall; Tyson Foods Posts Upbeat Earnings
November 13, 2023
U.S. stocks traded lower this morning, with the Nasdaq Composite falling around 100 points on Monday. Following the market opening Monday, the Dow traded down 0.08% to 34,254.53 while the NASDAQ fell...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Mainz Biomed Announces Pricing of $5.0 million Registered Direct Offering
November 13, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Partners With Liquid Biosciences In Exclusive Relationship To Harness The Power Of Artificial Intelligence (AI) To Develop Next-Generation Colorectal Screening Test
November 13, 2023
The integration of Artificial Intelligence (AI) in biotechnology is rapidly gaining momentum, revolutionizing the field of life sciences. AI technologies, such as machine learning and deep learning...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test
November 09, 2023
Collaboration to utilize cutting-edge AI analysis platform for clinical trials and cancer screening test processing
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed’s (NASDAQ: MYNZ) ColoFuture Study Reveals “Groundbreaking Results”: ColoAlert® Raises The Bar For Colorectal Cancer Detection
November 08, 2023
--News Direct--
Via
News Direct
Topics
Death
Exposures
Death
AI Meets Oncology! Mainz Biomed Inks Pact With Liquid Biosciences To Develop Next-Gen Colorectal Cancer Screening Test
November 07, 2023
Mainz Biomed N.V. (NASDAQ: MYNZ) inked a pact with Liquid Biosciences, a bio-analytics company leveraging its proprietary AI analysis technology platform (EMERGE), to enhance the
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
BioNTech Shifted Its Focus To Innovative Oncology And Mainz Biomed Announced A Showcasing Of Its Revolutionary Colorectal Cancer Detection Test
November 07, 2023
On November 6th, BioNTech SE (NASADQ: SE) who partnered with Pfizer Inc (NYSE: PFE) in the making of a blockbuster COVID-19 vaccine, posted a surprise earnings with its latest quarterly report.
Via
Benzinga
Exposures
COVID-19
Mainz Biomed to Showcase ColoAlert® at Leading Global Healthcare Event, MEDICA
November 07, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed's (NASDAQ: MYNZ) ColoFuture Study Reveals "Groundbreaking Results": ColoAlert® Raises The Bar For Colorectal Cancer Detection
November 07, 2023
Throughout the world, colorectal cancer has emerged as the third most prevalent form of cancer.
Via
Benzinga
Splunk Layoffs 2023: What to Know About the Latest SPLK Job Cuts
November 01, 2023
Splunk layoffs are on the way for 7% of the cybersecurity company's global employees as it continues a restructuring plan.
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Why Is WeWork (WE) Stock Down 38% Today?
November 01, 2023
WeWork stock is falling on Wednesday as investors in WE shares react to reports that the company is considering a bankruptcy filing.
Via
InvestorPlace
Topics
Bankruptcy
Exposures
Financial
Legal
Why Is Paycom Software (PAYC) Stock Down 39% Today?
November 01, 2023
Paycom Software stock is falling hard on Wednesday as investors in PAYC go over the company's mixed earnings report for Q3 2023!
Via
InvestorPlace
Why Is Mainz Biomed (MYNZ) Stock Moving Today?
November 01, 2023
Mainz Biomed stock is on the move Wednesday as investors in MYNZ react to results from a colorectal cancer screening test campaign.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 01, 2023
We're starting off Wednesday with a breakdown of the biggest pre-market stock movers investors will want to keep track of today!
Via
InvestorPlace
Today's Pharma Tales Of Loss And Success: Pfizer Swings To A Quarterly Loss And Mainz Biomed Reports Positive Interim Screening Campaign Results
October 31, 2023
As it struggles to navigate the rapid decline of its Covid-19 fame, Pfizer Inc (NYSE: PFE) reported a quarterly loss for the third quarter.
Via
Benzinga
Exposures
COVID-19
Mainz Biomed Reports Success from Employee Colorectal Cancer Screening Campaign in Partnership with Zöller-Kipper
October 31, 2023
Almost half of Zöller-KipperGmbH’s employees in Germany participated in the screening program so far using ColoAlert®, Mainz Biomed’s user-friendly, at-home colorectal cancer (CRC) screening test
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Appoints Tarrin Khairi-Taraki as VP of Commercial Operations
October 26, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Presents Groundbreaking Results of ColoFuture Study
October 18, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Johnson & Johnson Was Saved By Its Focus On MedTech And Innovative Medicine
October 17, 2023
Johnson & Johnson (NYSE: JNJ) reported its third quarter results that topped Wall Street’s expectations while also lifting its full year guidance fueled by a strong performance of its pharmaceutical...
Via
Benzinga
Mainz Biomed to Showcase ColoAlert® at UEG Week 2023 in Copenhagen, Denmark
October 11, 2023
Mainz Biomed team members will be available throughout the event at the Company’s booth located in Hall C, Stand C3-92
From
Mainz BioMed NV
Via
GlobeNewswire
Big Pharma Could Transform Into BioTech Pharma
October 10, 2023
As the word itself says, biotechnology is simply technology based on biology. It uses the knowledge of cellular and biomolecular processes to develop technologies that improve our lives and overall...
Via
Benzinga
Mainz Biomed to Attend the JonesTrading 2023 Healthcare Summit
October 05, 2023
From
Mainz BioMed NV
Via
GlobeNewswire
Mainz Biomed Continues To Transform Early Cancer Detection Across The Globe
October 04, 2023
While Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA) are making great progress in cancer treatments, the importance of early detection in combating this disease cannot be overstated.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.